Histamine inhibits adrenocortical cell proliferation but does not affect steroidogenesis

J Endocrinol. 2014 Mar 7;221(1):15-28. doi: 10.1530/JOE-13-0433. Print 2014 Apr.

Abstract

Histamine (HA) is a neurotransmitter synthesized in most mammalian tissues exclusively by histidine decarboxylase enzyme. Among the plethora of actions mediated by HA, the modulatory effects on steroidogenesis and proliferation in Leydig cells (LCs) have been described recently. To determine whether the effects on LCs reported could be extrapolated to all steroidogenic systems, in this study, we assessed the effect of this amine on adrenal proliferation and steroidogenesis, using two adrenocortical cell lines as experimental models, murine Y1 cells and human NCI-H295R cells. Even when steroidogenesis was not modified by HA in adrenocortical cells, the biogenic amine inhibited the proliferation of H295R cells. This action was mediated by the activation of HRH1 subtype and an increase in the production of inositol phosphates as second messengers, causing cell-cycle arrest in the G2/M phase. These results indicate a new role for HA in the proliferation of human adrenocortical cells that could contribute to a better understanding of tumor pathology as well as to the development of new therapeutic agents.

Keywords: adrenocortical cells; histamine; proliferation; steroidogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Cortex / cytology*
  • Adrenal Cortex / metabolism*
  • Animals
  • Cell Line
  • Cell Proliferation*
  • G2 Phase Cell Cycle Checkpoints
  • Histamine / metabolism*
  • Humans
  • M Phase Cell Cycle Checkpoints
  • Mice
  • Steroids / metabolism*

Substances

  • Steroids
  • Histamine